CIBC Asset Management’s Nutex Health NUTX Stock Holding History

CIBC Asset Management’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-124	Closed	-$35.3K	–	1115
2022 Q4	$35.3K	Buy	+124	New	+$23.8K	﹤0.01%	1038

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CIBC Asset Management's NUTX Position: Q1 2023 in Review

CIBC Asset Management sold out of Nutex Health (NUTX) in Q1 2023, closing a stake of 124 shares — an estimated $35.3K sold.

CIBC Asset Management first reported a position in NUTX in Q4 2022 and held it in 1 quarter. The position peaked at $35.3K in Q4 2022. 82 funds tracked by Wall St. Rank hold NUTX as of Q1 2023.

CIBC Asset Management reported no remaining Nutex Health position as of Q1 2023 after selling out during the quarter.
CIBC Asset Management sold 124 Nutex Health shares in Q1 2023, an estimated $35.3K.
CIBC Asset Management first reported a position in Nutex Health in Q4 2022 and held it in 1 quarter.
CIBC Asset Management's Nutex Health position peaked at $35.3K in Q4 2022.
82 funds tracked by Wall St. Rank held Nutex Health as of Q1 2023.

Based on CIBC Asset Management's 13F filing for Q1 2023, filed 12 May 2023.